U.S. Panel Backs COVID-19 Boosters Only for Elderly, High-risk
Some are calling the vote a major blow to the Biden administration
Today, an influential federal advisory panel soundly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans. It did, however, endorse the extra shots for those who are 65 or older or run a high risk of severe disease.
The twin votes Friday represented a heavy blow to the Biden administration's sweeping effort to shore up nearly all Americans' protection amid the spread of the highly contagious delta variant.
The decision was made by a committee of outside experts who advise the Food and Drug Administration (FDA). The vote Friday rejecting widespread booster shots was struck down 16-2.
Please select this link to read the complete article from WBNS-10TV.